Exelixis
EXEL
#1623
Rank
$9.73 B
Marketcap
$34.77
Share price
-5.21%
Change (1 day)
46.77%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company